Overview

Gender

male

Anthony DiGiandomenico joined our board of directors in June 2015. He has served on the boards of directors of ENDRA Life Sciences Inc., a developer of enhanced ultrasound technology, since July 2013, and Provention Bio, Inc., a biopharmaceutical company, since April 2017. Since he co-founded MDB Capital Group in 1997, Anthony DiGiandomenico has been enabling investment into early-stage disruptive technologies. He has worked alongside a wide range of companies in the biotechnology, medical devices, high technology, and renewable energy spaces. Anthony DiGiandomenico holds an MBA from the Haas School of Business at the University of California, Berkeley and a B.S. in Finance from the University of Colorado.